代表性成果
1、Zhen Zhuang#, Xiaomin Lai#, Jing Sun#, Zhao Chen#, …, Nanshan Zhong, Jingxian Zhao*, Dongsheng Zhou*, Jincun Zhao*. Mapping and Role of T Cell Response in SARS-CoV-2 infected Mice. J Exp Med (2021) 218 (4): e20202187.
2、Jing Sun#, Zhen Zhuang#, Jian Zheng#, Kun Li#, …, Paul B. McCray, Jr.*, Stanley Perlman*, Jincun Zhao*. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020, 182, 1–10.
3、Zhen Zhuang#, Jiaying Luo#, Guoxian Zhang#, Yifang He#, …, Jingxian Zhao*, Jing Sun*, Jincun Zhao*. Unveiling the Epitope Repertoires and Protective Roles of MERS-CoV-Specific T-Cells in Mice. Cell reports. Cell Rep. 2026 Feb 26;45(3):117043
4、Zhen Zhuang#, Donglan Liu#, Jing Sun#, Fang Li#, Jincun Zhao*. Immune responses to human respiratory coronaviruses infection in mouse models. Current Opinion in Virology. Volume 52, February 2022, Pages 102-111.
5、Zhen Zhuang#, Jianfen Zhuo#, …, Jincun Zhao*. Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections. Vaccines. 2024 Apr 29;12(5):478. doi: 10.3390/vaccines12050478.
6、Yin-Feng Kang#, Cong Sun#, Zhen Zhuang#, Run-Yu Yuan#, …, Guo-Kai Feng*, Changwen Ke*, Jin-Cun Zhao*, Mu-Sheng Zeng*. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates. ACS Nano. 2021 Feb 23;15(2):2738-2752.
7、Yaoxing Wu#, Ling Ma#, Zhen Zhuang#, Sihui Cai#, …, Jincun Zhao*, Jun Cui*. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduction and Targeted Therapy. 2020. 5:22
8、Yaoxing Wu#, Ling Ma#, Sihui Cai#, Zhen Zhuang#, …, Jincun Zhao* and Jun Cui*. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation. Signal Transduction and Targeted Therapy 2021 Apr 24;6(1):167.
9、Jing Sun#, Airu Zhu#, Heying Li#, Kui Zheng#, Zhen Zhuang#, Zhao Chen#, …, Nanshan Zhong, Zifeng Yang*, Jicheng Huang*, Jincun Zhao*, Yi-min Li*. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerging Microbes & Infections. 2020, VOL. 9.
10、Ming Liu#, Bingtai Lu#, Yue Li#, Shuofeng Yuan#, Zhen Zhuang#, Guangyu Li, …, Jincun Zhao*, Jasper Fuk-Woo Chan*, Yuxia Zhang*. P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation. Signal Transduction and Targeted Therapy (2023) 8:385